ES2038654T3 - Un procedimiento para preparar derivados de tianafteno. - Google Patents
Un procedimiento para preparar derivados de tianafteno.Info
- Publication number
- ES2038654T3 ES2038654T3 ES198787300759T ES87300759T ES2038654T3 ES 2038654 T3 ES2038654 T3 ES 2038654T3 ES 198787300759 T ES198787300759 T ES 198787300759T ES 87300759 T ES87300759 T ES 87300759T ES 2038654 T3 ES2038654 T3 ES 2038654T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- alkyl
- formula
- esters
- substituents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- -1 phthalidyl ester Chemical class 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 150000002148 esters Chemical class 0.000 abstract 4
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000002883 imidazolyl group Chemical group 0.000 abstract 3
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 abstract 3
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 2
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Chemical group 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Liquid Crystal Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Un procedimiento para preparar compuestos de fórmula (Ii) o (Iii ): **fórmula** donde: R1 y R2 son iguales o diferentes y cada uno representa un átomo de hidrógeno o, un grupo alquilo C1-C4; n es 1 ó 2; uno de A 1 y A 2 representa un grupo de fórmula -Z-Y donde Y representa un grupo imidazolilo o piridilo y Z representa un grupo metilemo, etileno o vinileno o un grupo metileno, etileno o vinileno que tiene al menos uno de los sustituyentes (b); el otro de A 1 y A 2 representa un grupo de fórmula -W-COOH, donde W representa un enlace directo, un grupo metileno, un grupo metino, un grupo etileno, un grupo vinileno o un grupo metileno, metino, etileno o vinileno sustituido que tiene al menos uno de los sustituyentes (c), siempre que W sólo represente dicho grupo metino cuando A 1 representa dicho grupo de fórmula -Z-Y; la línea discontinua representa un enlace carbono-carbono sencillo o doble entre las posiciones 4 y 5 ó 6 y 7; con lo que los sustituyentes (b) se seleccionan entre grupos alquilo C1-C4, grupos cicloalquilo C3-C6, grupos arilo C6-C10, y grupos arilo C6-C10 sustituidos que tienen al menos uno de los sustituyentes alquilo C1-C4, alcoxi C1-C4, ohalógeno; y los sustituyentes (c) se seleccionan entre grupos alquilo C1-C4 y grupos arilo C6-C10; y las sales, amidas y ésteres de los mismos farmacéuticamente aceptables, siendo los ésteres ésteres alquílicos C1-C6, ésteres aralquílicos, ésteres diaralquílicos, ésteres alcoxicarbonilalquílicos, donde las porciones alcoxi y alquilo son ambas ésteres alcoxicarbonilalquílicos, donde las porciones alcoxi y alquilo son ambas éster ftalidílico C1-C4, éster fenacílico C1-C4, éster p-nitrofenacílico C1-C4, éster (5-metil-2-oxo-1,3-dioxolen-4-il)metílico C1-C4 o éster (5-fenil-2-oxo-1,3-dioxolen-4-il)metílico C1-C4, y siendo las amidas aquellas que tienen un grupo carbamoílo, un grupo alquilcarbamoílo o dialquilcarbamoílo donde el grupo alquilo o cada grupo alquilo es un grupo alquilo C1-C4 cuyo procedimiento comprende hacer reaccionar un compuesto de fórmula (IIi) o(IIii): **fórmula** (donde R1, R2, n y las líneas discontinuas se definen como antes; uno de B1 y B2 representa el grupo de fórmula -W-COOH representado por A1 o A2 o un grupo tal en el que el grupo carboxi está protegido; y el otro de B 1 y B 2 representa un grupo activo) con un compuesto de imidazolilo o piridilo para introducir el grupo imidazolilo o piridilo representado por Y en dicho compuesto y, si fuerea necesario; someter el compuesto resultante a reducción y/o hidrólisis y/o desprotección.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1650186 | 1986-01-28 | ||
| JP61228769A JPH0696577B2 (ja) | 1986-09-27 | 1986-09-27 | チアナフテン誘導体およびその製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2038654T3 true ES2038654T3 (es) | 1993-08-01 |
Family
ID=26352848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198787300759T Expired - Lifetime ES2038654T3 (es) | 1986-01-28 | 1987-01-28 | Un procedimiento para preparar derivados de tianafteno. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US4847272A (es) |
| EP (1) | EP0240107B1 (es) |
| KR (1) | KR920002129B1 (es) |
| CN (1) | CN1023013C (es) |
| AT (1) | ATE66476T1 (es) |
| AU (1) | AU591750B2 (es) |
| CA (1) | CA1301172C (es) |
| DE (1) | DE3772235D1 (es) |
| DK (1) | DK45987A (es) |
| ES (1) | ES2038654T3 (es) |
| FI (1) | FI95252C (es) |
| HU (1) | HU207313B (es) |
| IE (1) | IE59655B1 (es) |
| NO (1) | NO166644C (es) |
| SU (1) | SU1739848A3 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990563A (en) * | 1958-12-03 | 1961-07-04 | Guild Molders | Applicator device |
| US4992090A (en) * | 1988-06-13 | 1991-02-12 | Ciba-Geigy Corporation | Herbicidally active 5,6-dihydrocyclopentathiophenyl-imidazole derivatives |
| EP0457716A1 (de) * | 1990-04-20 | 1991-11-21 | Ciba-Geigy Ag | Naphthalinderivate |
| TW224461B (es) * | 1990-09-18 | 1994-06-01 | Ciba Geigy Ag | |
| US5364869A (en) * | 1992-03-09 | 1994-11-15 | Abbott Laboratories | Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists |
| DE69528860T2 (de) * | 1994-06-30 | 2003-07-10 | Kuraray Co., Ltd | 1-Amino-2-Cyclohexenderivate und Verfahren zu ihrer Herstellung |
| WO1999064425A1 (en) * | 1998-06-09 | 1999-12-16 | Neurogen Corporation | Substituted thienocycloalkylpyrazoles: dopamine receptor subtype specific ligands |
| CA2708281A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| GB2477648B (en) * | 2008-08-29 | 2013-02-20 | Lee H Angros | In situ heat induced antigen recovery and staining apparatus and method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK471479A (da) | 1978-12-13 | 1980-06-14 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
| GR75101B (es) * | 1980-10-23 | 1984-07-13 | Pfizer | |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| US4611059A (en) * | 1982-10-12 | 1986-09-09 | The Upjohn Company | Pyridyl-substituted benzothiophenes |
-
1987
- 1987-01-27 SU SU874028995A patent/SU1739848A3/ru active
- 1987-01-27 US US07/007,375 patent/US4847272A/en not_active Expired - Lifetime
- 1987-01-27 KR KR1019870000639A patent/KR920002129B1/ko not_active Expired
- 1987-01-27 NO NO870319A patent/NO166644C/no not_active IP Right Cessation
- 1987-01-28 FI FI870373A patent/FI95252C/fi not_active IP Right Cessation
- 1987-01-28 EP EP87300759A patent/EP0240107B1/en not_active Expired - Lifetime
- 1987-01-28 DE DE8787300759T patent/DE3772235D1/de not_active Expired - Fee Related
- 1987-01-28 AT AT87300759T patent/ATE66476T1/de not_active IP Right Cessation
- 1987-01-28 HU HU87258A patent/HU207313B/hu not_active IP Right Cessation
- 1987-01-28 AU AU68114/87A patent/AU591750B2/en not_active Ceased
- 1987-01-28 CN CN87102672A patent/CN1023013C/zh not_active Expired - Fee Related
- 1987-01-28 CA CA000528417A patent/CA1301172C/en not_active Expired - Fee Related
- 1987-01-28 IE IE21787A patent/IE59655B1/en not_active IP Right Cessation
- 1987-01-28 DK DK045987A patent/DK45987A/da not_active Application Discontinuation
- 1987-01-28 ES ES198787300759T patent/ES2038654T3/es not_active Expired - Lifetime
-
1989
- 1989-05-19 US US07/354,984 patent/US5021444A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO166644B (no) | 1991-05-13 |
| CA1301172C (en) | 1992-05-19 |
| AU6811487A (en) | 1987-07-30 |
| FI870373A0 (fi) | 1987-01-28 |
| DK45987D0 (da) | 1987-01-28 |
| HUT43593A (en) | 1987-11-30 |
| DE3772235D1 (de) | 1991-09-26 |
| CN87102672A (zh) | 1987-11-04 |
| AU591750B2 (en) | 1989-12-14 |
| US5021444A (en) | 1991-06-04 |
| US4847272A (en) | 1989-07-11 |
| HU207313B (en) | 1993-03-29 |
| FI870373L (fi) | 1987-07-29 |
| FI95252B (fi) | 1995-09-29 |
| SU1739848A3 (ru) | 1992-06-07 |
| DK45987A (da) | 1987-07-29 |
| CN1023013C (zh) | 1993-12-08 |
| EP0240107B1 (en) | 1991-08-21 |
| ATE66476T1 (de) | 1991-09-15 |
| EP0240107A1 (en) | 1987-10-07 |
| NO870319L (no) | 1987-07-29 |
| IE870217L (en) | 1987-07-28 |
| FI95252C (fi) | 1996-01-10 |
| NO870319D0 (no) | 1987-01-27 |
| KR920002129B1 (ko) | 1992-03-12 |
| KR870007153A (ko) | 1987-08-17 |
| IE59655B1 (en) | 1994-03-09 |
| NO166644C (no) | 1991-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
| DK164701C (da) | Thiazolidinderivater, deres fremstilling og midler, som indeholder dem | |
| RU94031155A (ru) | Амидин - производные, способ их получения, их использование в качестве ингибиторов no - синтазы, фармсостав, способ лечения | |
| CO4940458A1 (es) | Novedosos inhibidores de urea n-sustituida de transferasa de proteina farnesilo | |
| ES2058091T3 (es) | Derivados de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico y procedimientos para su preparacion. | |
| DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
| GB1260848A (en) | Propanolamine derivatives | |
| KR870700067A (ko) | 피리도(2,3-d)-피리미딘 유도체 | |
| ES2185634T3 (es) | Derivados de cefalosporina. | |
| DK0779886T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er anvendelige som antiinflammatoriske midler | |
| PT81855B (pt) | Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem | |
| NO20000722L (no) | 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater | |
| AR019674A1 (es) | Compuestos antitromboticos y composiciones farmaceuticas que los contienen | |
| GB1291675A (en) | 0-(1,3,4-thiadiazol-2-yl)-imidazolidinone(2) derivatives, process for their production and their use as herbicidal agents | |
| KR940009163A (ko) | 벤질리덴 유도체 | |
| ES2101059T3 (es) | Derivados biciclicos nitrogenados, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| PT87025A (pt) | Process for the preparation of imidazol derivatives and of pharmaceutical compositions containing the same | |
| NO870319L (no) | Tianaftenderivater og fremgangsmaate til fremstilling derav | |
| SE8207092D0 (sv) | Forfarande for framstellning av optiskt aktiva penemer | |
| BG96487A (bg) | Р-заместени производни на 4-оксибутанамина,методи за получаването им и тяхното приложение | |
| DK0486385T3 (da) | Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK185984D0 (da) | Disubstituerede polymethyleniminer,fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende dem | |
| PT84419B (pt) | Processo de preparacao de derivados penemicos e de composicoes farmaceuticas e veterinarias que os contem | |
| EA199900589A1 (ru) | Производные эритромицина, способ их получения и их применение в качестве лекарственных средств | |
| CO4940470A1 (es) | Compuestos 5,6,7-trisustituidos-4-aminopirido[2,3-d]pirimi- dina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 240107 Country of ref document: ES |